Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dabuyin Wan is a classical Traditional Chinese Medicine (TCM) formulation presented as a dark brownish-black water-honeyed pill. It is a multi-ingredient herbal preparation composed of five primary ingredients: Radix Rehmanniae Preparata (Shudi Huang), Rhizoma Anemarrhenae (Zhimu), Cortex Phellodendri (Huangbai), processed Carapax et Plastrum Testudinis (Guiban), and Medulla Spinalis Suis (Zhuizhui). In TCM practice, it is used to 'nourish yin and lower fire,' and is indicated for conditions involving yin deficiency with flaming-up of fire, manifested by symptoms such as daily recurring fever, night sweating, cough, hemoptysis, tinnitus, and seminal emission. Modern research has investigated its potential in treating central precocious puberty (CPP) and early puberty in children. The proposed mechanism involves the down-regulation of Kiss-1/GPR54 mRNA expression in the hypothalamus, which inhibits the synthesis and release of gonadotropin-releasing hormone (GnRH), thereby suppressing the hypothalamic-pituitary-gonadal axis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dabuyin Wan.